Hepatic and Metabolic Effects of Ethanol: Pathogenesis and Prevention

References

• Lieber C S. Medical and nutritional complications of alcoholism: mechanisms and management. Plenum Press, New York 1992; 579
   Google Scholar
• Nikkilä E, Ojala K. Role of hepatic L-a-glyceropsphate and triglyceride synthesis in production of fatty liver by ethanol. Proc Soc Exp Biol Med 1969; 113: 814–7
   Google Scholar
• Hernández-Muñoz R, Caballeria J, Baraona E, Uppal Ft, Greenstein R, Lieber C S. Human gastric alcohol dehydrogenase: its inhibition by H2-receptor antagonists, and its effect on the bioavailability of ethanol. Alcohol Clin Exp Res 1990; 14: 946–50
   PubMed Web of Science ®Google Scholar
• Julkunen R JK, DiPadova C, Lieber C S. First pass metabolism of ethanol a gastrointestinal barrier against the systemic toxicity of ethanol. Life Sci 1985; 37: 567–73
   PubMed Web of Science ®Google Scholar
• Caballeria J, Frezza M, Hernández-Muñoz R, et al. The gastric origin of the first-pass metabolism of ethanol in man: effect of gastrectomy. Gastroenterology 1989; 97: 1205–9
   PubMed Web of Science ®Google Scholar
• Caballeria J, Baraona E, Deulofeu R, Hernández-Muñoz R, Rodes J, Lieber C S. Effects of H2-receptor antagonists on gastric alcohol dehydrogenase activity. Dig Dis Sci 1991; 36: 1673–97
   PubMed Web of Science ®Google Scholar
• Faller J, Fox I H. Evidence for increased urate production by activation of adenine nucleotide turnover. N Engl J Med 1982; 307: 1598–1602
   PubMed Web of Science ®Google Scholar
• Lieber C S, DeCarli L M. Hepatotoxicity of ethanol. J Hepatol 1991; 12: 394–401
   PubMedGoogle Scholar
• Lieber C S, Spritz N. Effect of prolonged ethanol intake in man: role of dietary, adipose, and endogenously synthesized fatty acids in the pathogenesis of the alcoholic fatty liver. J Clin Invest 1966; 45: 1400–11
   PubMed Web of Science ®Google Scholar
• Israel Y, Kalant H, Orrego H, Khanna J M, Videla I, Phillips J M. Experimental alcohol-induced hepatic necrosis: suppression by propylthiouracil. Proc Natl Acad Sci USA 1975; 72: 1137–41
   PubMed Web of Science ®Google Scholar
• Lieber C S, Baraona E, Hernández-Muñoz R, et al. Impaired oxygen utilization: a new mechanism for the hepatotoxicity of ethanol in sub-human primates. J Clin Invest 1989; 83: 1682–90
   PubMed Web of Science ®Google Scholar
• Jauhonen P, Baraona E, Miyakawa H, Lieber C S. Mechanism for selective perivenular hepatoxicity of ethanol. Alcohol Clin Exp Res 1982; 6: 350–7
   PubMedGoogle Scholar
• Kato S, Kawase T, Alderman J, Inatomi N, Lieber C S. Role of xanthine oxidase in ethanol-induced lipid peroxidation in rats. Gastroenterology 1990; 98: 203–10
   PubMed Web of Science ®Google Scholar
• Lieber C S, Robins S J, Leo M A. Hepatic phosphatidylethanolamine methyltransferase activity is decreased by ethanol and increased by phosphatidylcholine. Alcohol Clin Exp Res 1994; 18: 592–5
   PubMed Web of Science ®Google Scholar
• Arai M, Gordon E R, Lieber C S. Decreased cytochrome oxidase activity in hepatic mitochondria after chronic ethanol consumption and the possible role of decreased cytochrome aa3 content and changes in phospholipids. Biochim Biophys Acta 1984; 797: 320–7
   PubMedGoogle Scholar
• Arai M, Leo M A, Nakano M, Gordon E R, Lieber C S. Biochemical and morphological alterations of baboon hepatic mitochondria after chronic ethanol consumption. Hepatology 1984; 4: 165–74
   PubMed Web of Science ®Google Scholar
• Duce A M, Ortiz P, Cabrero C, Mato J M. S-adenosyl-L-methionine synthetase and phospholipid methyltransferase are inhibited in human cirrhosis. Hepatology 1988; 8: 65–8
   PubMed Web of Science ®Google Scholar
• Savolainen M, Baraona E, Leo M A, Lieber C S. Pathogenesis of the hypertriglyceridemia at early stages of alcoholic liver injury in the baboon. J Lipid Res 1986; 27: 1073–83
   PubMedGoogle Scholar
• Lieber C S, DeCarli L M. Hepatic microsomal ethanol oxidizing system: in vitro characteristics and adaptive properties in vivo. J Biol Chem 1970; 245: 2505–12
   PubMed Web of Science ®Google Scholar
• Tsutsumi M, Lasker J M, Shimizu M, Rosman A S, Lieber C S. The intralobular distribution of ethanol-inducible P450E1 in rat and human liver. Hepatology 1989; 10: 437–46
   PubMed Web of Science ®Google Scholar
• Takahashi T, Lasker J M, Rosman A S, Lieber C S. Induction of P450E1 in human liver by ethanol is due to a corresponding increase in encoding mRNA. Hepatology 1993; 17: 236–45
   PubMed Web of Science ®Google Scholar
• Tsutsumi M, Lasker J M, Takahashi T, Lieber C S. In vivo induction of hepatic P4502E1 by ethanol: role of increased enzyme synthesis. Arch Biochem Biophys 1993; 304: 209–18
   PubMed Web of Science ®Google Scholar
• Lieber C S, Garro A, Leo M A, Mak K M, Worner T. Alcohol and cancer. Hepatology 1986; 6: 1005–19
   PubMed Web of Science ®Google Scholar
• Garro A J, Lieber C S. Alcohol and cancer. Annu Rev Pharmacol Toxicol 1990; 30: 219–49
   PubMed Web of Science ®Google Scholar
• Leo M A, Lieber C S. Hepatic vitamin A depletion in alcoholic liver injury. N Engl J Med 1982; 307: 597–601
   PubMed Web of Science ®Google Scholar
• Leo M A, Rosman A, Lieber C S. Differential depletion of carotenoids and tocopherol in liver diseases. Hepatology 1993; 17: 977–86
   PubMed Web of Science ®Google Scholar
• Leo M A, Lieber C S. New pathway for retinol metabolism in liver microsome. J Biochem 1985; 260: 5228–31
   Google Scholar
• Leo M A, Kim C I, Lieber C S. NAD+-dependent retinol dehydrogenase in liver microsome. Arch Biochem Biophys 1987; 259: 241–9
   PubMed Web of Science ®Google Scholar
• Leo M A, Lida S, Lieber C S. Retinoic acid metabolism by a system reconstituted with cytochrome P-450. Arch Biochem Biophys 1984; 234: 305–12
   PubMed Web of Science ®Google Scholar
• Leo M A, Kim C I, Lowe N, Lieber C S. Interaction of ethanol with β-carotene: delayed blood clearance and enhanced hepatotoxicity. Hepatology 1992; 15: 883–91
   PubMed Web of Science ®Google Scholar
• Ahmed S, Leo M A, Lieber C S. Interactions between alcohol and β-carotene in patients with alcoholic liver disease. Am J Clin Nutr 1994, (in press)
   PubMedGoogle Scholar
• Alpha-Tocopherol, β-carotene Cancer Prevention Study Group. N Engl J Med 1994; 330: 1029–35
   Google Scholar
• Ma X-L, Baraona E, Lieber C S. Alcohol consumption enhances fatty acid ω-oxidation, with a greater increase in male than in female rats. Hepatology 1994; 18: 1247–53
   Google Scholar
• Kaikaus R M, Chan W K, Lysenko N, Ortiz P, Montellano D, Bass N M. Induction of liver fatty acid binding protein (1-FABP) and peroxisomal fatty acid β-oxidation by peroxisome proliferators (PP) is dependent on cytochrome p-450 activity. Hepatology 1990; 12: A248
   Google Scholar
• Handler J A, Thurman R G. Fatty acid-dependent ethanol metabolism. Biochem Biophys Res Commun 1985; 133: 44–51
   PubMed Web of Science ®Google Scholar
• Williamson, Jr, Scholz R, Browning E T, Thurman R G, Fukami M H. Metabolic effects of ethanol in perfused rat liver. J Biol Chem 1969; 25: 5044–54
   Google Scholar
• Laposata E A, Lange L G. Presence of nonoxidative ethanol metabolism in human organs commonly damaged by ethanol abuse. Science 1986; 231: 497–9
   PubMed Web of Science ®Google Scholar
• Di Padova C, Worner T M, Julkunen R JK, Lieber C S. Effects of fasting and chronic alcohol consumption on the first pass metabolism of ethanol. Gastroenterology 1987; 92: 1169–73
   PubMed Web of Science ®Google Scholar
• Lieber C S, Casini A, DeCarli L M, Kim C, Lowe N, Sasaki R, Leo M A. S-adenosyl-L-methionine attenuates alcohol-induced liver injury in the baboon. Hepatology 1990; 11: 165–72
   PubMed Web of Science ®Google Scholar
• Crouse J R, Gerson C D, DeCarli L M, Lieber C S. Role of acetate in the reduction of plasma free fatty acids produced by ethanol in man. J Lipid Res 1968; 9: 509–12
   PubMed Web of Science ®Google Scholar
• Schenker S, Halff G A. Nutritional therapy in alcoholic liver disease. Semin Liver Dis 1993; 13: 196–209
   PubMed Web of Science ®Google Scholar
• Lieber C S, Robins S J, Li J, et al. Phosphatidylcholine protects against fibrosis and cirrhosis in the baboon. Gastroenterology 1994; 106: 152–9
   PubMed Web of Science ®Google Scholar
• Ramond M J, Poynard T, Rueff B. A randomized trial of prednisolone in patients with severe alcoholic hepatitis. N Engl J Med 1992; 326: 507–12
   PubMed Web of Science ®Google Scholar
• Kershenobich D, Vargas F, Garcia-Tsao G, Tomayo P R, Gent M, Rojkind M. Colchicine in the treatment of cirrhosis of the liver. N Engl J Med 1988; 318: 1709–13
   PubMed Web of Science ®Google Scholar
• Worner T M, Lieber C S. Perivenular fibrosis as precursor lesion of cirrhosis. JAMA 1985; 254: 627
   PubMedGoogle Scholar
• Lieber C S. Alcohol and the liver: 1994 update. Gastroenterology 1994; 106: 1085–106
   PubMed Web of Science ®Google Scholar